Trimeris Resolves Accounting Question
13th Nov 2006, 16:15 GMT
Biopharmaceutical company Trimeris said it resolved an accounting question that arose during the final stages of preparing its quarterly report for the period ended 9/30/2006 and will now file the 10-Q.
Trimeris Resolves Accounting Question related news:
- Trimeris swaps CEOs, says it will slash jobs — Latest news from Triangle Business Journal
- Trimeris swaps CEOs, says it will slash jobs in restructuring — Latest news from Triangle Business Journal
- Accounting rule a sweeping change — bizjournals.com Business Services:Accounting & Consulting headlines
- Accounting software has come a long way under Linux — Linux.com
- Movie Gallery delays earnings release to resolve lease accounting questions — bizjournals.com Business Services:Accounting & Consulting headlines
- Accounting software for project businesses — IT for manufacturing management and production latest news on Manufacturingtalk
- Firms outsource CPA tasks to keep up with high demand — bizjournals.com Business Services:Accounting & Consulting headlines
- Ford retraces accounting errors over 5 years — Latest news from Business First of Buffalo
- Linux.com: Ledger, The Bran Muffin of Accounting Tools — Linux Today
- Miami U. scores high marks for accounting program — bizjournals.com Business Services:Accounting & Consulting headlines
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Nabi Biopharmaceuticals and 3rd Point Reach Agreement
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress